In this video interview from the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), Asfand Yar Cheema, MD, resident physician at Cleveland Clinic Fairview Hospital, discusses his SOHO 2025 abstract on patients with polycythemia vera who received GLP-1a therapy. The abstract was honored with second place at the Annual Meeting’s award ceremony. He reviews how GLP-1 receptor agonists had markedly better outcomes than patients who did not, including reduced risks of all-cause mortality, and he outlines future research needs.
Dr. Cheema is the recipient of a SOHO Young Investigator award. The award is part of the Young Investigator Program (YIP), which provides scholarships to young investigators to attend the SOHO Annual Meeting. Learn how to donate today to the YIP program.
